Blocking HPA axis by low dose dexamethasone increased the anorexigenic property of Ex-4.
Dexamethasone/Ex-4 co-treatment reduced food intake and body weight in diet-induced obese rats more than Ex-4 alone.
A brain lesion model identified a potential central interaction between glucocorticoids and GLP-1 in food intake control.